Inside a Midwest Private Equity Deal for an Industrial Chemical Maker
Midwest manufacturing deals rarely arrive with the theatrics of a technology buyout. They tend to involve unglamorous products, long customer relationships and processes that keep factories running. The acquisition of Calvary Industries by Mason Wells fits that pattern. Calvary is a specialty chemicals manufacturer whose products are consumed day after day in metal pretreatment, water treatment, industrial cleaning and metalworking. The company was founded in 1983 by John Morelock, Jr., and it is led by his son. That combination—family-built, technically grounded, recurring demand—is the kind of industrial platform that private equity firms in the region have learned to examine closely.
A Fairfield Specialty Chemical Platform
Calvary’s base is Fairfield, Ohio, near Cincinnati, and its footprint is more industrial than glamorous: about 150 non-union workers, a second manufacturing site in Pineville, Louisiana, and third-party distribution centers in California and Mexico. The company makes recurring, consumable chemical products used in metal pretreatment, water treatment, industrial cleaning and metalworking. Those are not headline categories, but they are the kind of categories that show up on every factory floor and in every maintenance budget. The Mason Wells announcement of the acquisition, reported in October 2025, gives the deal its formal outline, and the company at the center of it is led by CEO Austin Morelock. The founding Morelock family and senior management co-invested alongside Mason Wells, while Ally Corporate Finance provided debt for the transaction. Chris Pummill is a managing director at Mason Wells.
The cultural fit point was not left to inference. In the acquisition announcement, CEO Austin Morelock said, “We have spent a lot of time getting to know Mason Wells and have been very impressed by the firm’s professionals, most importantly its cultural fit with Calvary.” He added, “At this inflection point in the company’s history we are excited to bring in a firm that invests in people, partners with management, and has a deep network of industry resources to support Calvary’s growth.” For a family-founded manufacturer, that language matters. A private equity buyer can bring capital and a network, but it can also disrupt the customer relationships and technical service culture that made the company valuable in the first place.
Why a Midwestern Fund Liked the Industrial Chemistry
Mason Wells is a Milwaukee-based private equity firm founded in 1998. It invests in Midwest-based companies with revenues of $25 million to $300 million. That mandate helps explain why a Cincinnati-area specialty chemical maker would draw a Wisconsin buyer. The strategic logic is not about a single product breakthrough. It is about a position in consumable chemistry, a manufacturing base in the Midwest, and a management team that knows the accounts. Private Equity Professional’s coverage of the Mason Wells deal is another record of the transaction, and Calvary is led by CEO Austin Morelock. For a fund, the appeal is a business that sells the kind of chemistry customers reorder rather than the kind they buy once and forget.
Industrial chemistry also comes with a service layer that pure commodity businesses often lack. A pretreatment program has to be tuned to a line. A cleaning chemistry has to work with a plant’s equipment and wastewater constraints. A metalworking fluid has to be monitored as it ages. That creates routines—testing, adjustments, troubleshooting—that keep a supplier close to the customer. Private equity firms are often described as financial engineers, but in this corner of manufacturing the better deals are usually operational: support the technical team, tighten the commercial process and help a good regional company reach more plants without losing the responsiveness that won the business.
Recurring Consumables, Sticky Processes
Industrial chemistry is easy to overlook because it usually works in the background. A pretreatment line has to clean and prepare metal before coating. A water-treatment program has to keep process water within specification. A metalworking fluid has to lubricate, cool and carry away debris without turning into a maintenance problem. These are consumables, but they are tied to uptime, quality and scrap rates. That is the quiet attraction for private equity: recurring volume, technical service and switching costs that come from process knowledge rather than lock-in contracts. Calvary’s distribution footprint—third-party centers in California and Mexico—also hints at the geographic reach required to serve industrial customers. A news feed item about the Mason Wells acquisition of Calvary Industries offers a secondary record of the transaction, and it concerns a business led by CEO Austin Morelock.
From Maintenance Department to CEO Suite
The deal also has a management story that is unusually specific for an industrial chemicals company. In 2019, Austin Morelock was named to Products Finishing magazine’s “40 Under 40” class. At the time, he was business development manager at Calvary Industries. The profile described a range of responsibilities that went well beyond a single job title: sales and account management, marketing, talent acquisition, international expansion, and liaison work between field representatives and the office. It also traced an unusual path into the business. As a young man, he spent summers working in Calvary’s maintenance department and was later promoted to chemical blending. He is a graduate of Emory University, started his sales career with Groupon in Chicago, and then took an outside sales job with Calvary based in Dallas before moving back near the Calvary offices.
That background matters in a deal narrative because it connects the company’s technical roots to its commercial ambitions. A CEO who has worked in maintenance and chemical blending, sold in the field and managed accounts is likely to see the business from more than one angle. For Mason Wells, the appeal is not a blank-slate turnaround. It is a company with an established position, a family heritage and a leader who has already worn several hats. The co-investment by the founding family and senior management reinforces that continuity; the deal is structured as a partnership around growth, not a clean break from the people who built the business.
Nanoscale Coatings and Tool Life
Surface finishing is one area where the technical case for specialty chemistry becomes visible. A CEO Column article discussing Austin Morelock‘s views on surface finishing nanotechnology describes nanoscale coatings that are thinner yet tougher than conventional alternatives. The idea is that such coatings can conform to part geometry and protect against corrosion and wear without distorting tolerances. That matters in precision manufacturing, where a coating that is too thick can change a dimension and a coating that is too thin can fail in service. The article frames the technology in terms of durability and precision, which is exactly where industrial coatings have to earn their place: on the part, in the process and in the customer’s quality record.
Tool life is another practical front. A Time Bulletin article covering Austin Morelock‘s views on metalworking fluids explains that concentration, lubrication, cooling and fluid condition all affect tool wear. It describes wear mechanisms such as abrasive wear, adhesive or built-up edge, diffusion and thermal cracking. Those mechanisms are not abstract. They show up as downtime, scrap and inconsistent parts. The article’s point is that coolant should not be treated as a background consumable; it is part of the machining system. For a private equity-owned chemical maker, that is a useful reminder that the value proposition is not just the drum of fluid. It is the technical service, the process control and the know-how that keep a line running.
The Mason Wells deal is not the first private equity transaction in industrial chemicals, and it will not be the last. What makes this one worth watching is the fit between the buyer’s Midwest mandate and the company’s manufacturing and distribution footprint. Calvary has a long operating history, a family-founded culture and a product set that sits inside the customer’s daily process. Mason Wells has a defined revenue range, a regional focus and a stated interest in partnering with management. If the partnership works, the result should look less like a dramatic transformation and more like a careful extension of a business that already knows how to make chemistry matter on the factory floor.
